EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof‐of‐concept study

Carlos Solano de la Asunción, Estela Giménez, Juan Carlos Hernández-Boluda, María José Terol, Eliseo Albert, Javier López, Valentín García-Gutiérrez, Rafael Andreu, María Dolores García Malo, María Laura Fox, María José Remigia, Paula Amat und 2 weitere

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28933 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Carlos Solano de la Asunción und 13 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Service, INCLIVA Research Institute, Hospital Clínico Universitario, Valencia, Spain. Hauptthemen laut MEDLINE: Torque teno virus, Cytomegalovirus Infections, Hematologic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is unknown whether Torque Teno virus (TTV) DNA load monitoring could anticipate the development of infectious events in hematological patients undergoing treatment with small molecular targeting agents. We characterized the kinetics of plasma TTV DNA in patients treated with ibrutinib or ruxolitinib and assessed whether TTV DNA load monitoring could predict the occurrence of Cytomegalovirus (CMV) DNAemia or the magnitude of CMV‐specific T‐cell responses. Multicenter, retrospective, observational study, recruiting 20 patients treated with ibrutinib and 21 with ruxolitinib. Plasma TTV and CMV DNA loads were quantified by real‐time PCR at baseline and days +15, +30, +45, +60, +75, +90, +120, +150, and +180 after treatment inception. Enumeration of CMV‐specific interferon‐γ (IFN‐γ)‐producing CD8 + and CD4 + T‐cells in whole blood was performed by flow cytometry. Median TTV DNA load in ibrutinib‐treated patients increased significantly ( p = 0.025) from baseline (median: 5.76 log 10 copies/mL) to day +120 (median: 7.83 log 10 copies/mL). A moderate inverse correlation (Rho = −0.46; p < 0.001) was found between TTV DNA load and absolute lymphocyte count. In ruxolitinib‐treated patients, TTV DNA load quantified at baseline was not significantly different from that measured after treatment inception ( p ≥ 0.12). TTV DNA load was not predictive of the subsequent occurrence of CMV DNAemia in either patient group. No correlation was observed between TTV DNA loads and CMV‐specific IFN‐γ‐producing CD8 + and CD4 + T‐cell counts in either patient group. The data did not support the hypothesis that TTV DNA load monitoring in hematological patients treated with ibrutinib or ruxolitinib could be useful to predict either the occurrence of CMV DNAemia or the level of CMV‐specific T‐cell reconstitution; nevertheless, due to the small sample size, further studies involving larger cohorts are warranted to elucidate this issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Torque teno virusCytomegalovirus InfectionsHematologic NeoplasmsHumansCytomegalovirusRetrospective StudiesDNA, ViralInterferon-gammaViral LoadNitrilesPyrazolesPyrimidines

Stichwörter der Autor:innen

CMVCMV DNAemiaCMV-specific T-cellsIbrutinibTTV DNA loadruxolitinib

Substanzen

DNA, ViralInterferon-gammaruxolitinibNitrilesPyrazolesPyrimidines

Autor:innen und Institutionen

  • Microbiology Service, INCLIVA Research Institute, Hospital Clínico Universitario, Valencia, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Hematology Service, INCLIVA Research Institute, Hospital Clínico Universitario, Valencia, Spain.
  • Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.
  • Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Hematology Service, Hospital Universitario Politécnico "La Fe", Valencia, Spain.

ORCID-Profile: David Navarro

Zitieren

APA

de la Asunción, C. S., Giménez, E., Hernández-Boluda, J. C., Terol, M. J., Albert, E., López, J., García-Gutiérrez, V., Andreu, R., Malo, M. D. G., Fox, M. L., Remigia, M. J., Amat, P., Solano, C., & Navarro, D. (2023). Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof‐of‐concept study. Journal of Medical Virology. https://doi.org/10.1002/jmv.28933

Vancouver

de la Asunción CS, Giménez E, Hernández-Boluda JC, Terol MJ, Albert E, López J, et al. Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof‐of‐concept study. Journal of Medical Virology. 2023. doi:10.1002/jmv.28933

BibTeX
@article{delaAsuncin2023,
  author = {de la Asunción, Carlos Solano and Giménez, Estela and Hernández-Boluda, Juan Carlos and Terol, María José and Albert, Eliseo and López, Javier and García-Gutiérrez, Valentín and Andreu, Rafael and Malo, María Dolores García and Fox, María Laura and Remigia, María José and Amat, Paula and Solano, Carlos and Navarro, David},
  title = {Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof‐of‐concept study},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28933}
}
Kostenlos starten →